These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18119558)

  • 21. THE BONE MARROW IN SYSTEMIC LUPUS ERYTHEMATOSUS.
    BURKHARDT R
    Semin Hematol; 1965 Jan; 2():29-46. PubMed ID: 14268736
    [No Abstract]   [Full Text] [Related]  

  • 22. ROLE OF TEMPERATURE IN THE PRODUCTION OF THE L.E. (LUPUS ERYTHEMATOSUS) CELL PHENOMENON.
    BENCZE G; LAKATOS L
    Ann Rheum Dis; 1963 Sep; 22(5):354-5. PubMed ID: 14059297
    [No Abstract]   [Full Text] [Related]  

  • 23. [Observations on changes in the leukocyte pattern and methodical studies of the LE cell phenomenon in disseminated lupus erythematodes].
    Hoigné R; Bütikofer E; Vögeli H
    Schweiz Med Wochenschr; 1966 Sep; 96(37):1229-32. PubMed ID: 4171965
    [No Abstract]   [Full Text] [Related]  

  • 24. [The lupus erythematosus (L.E.) cell].
    BENCZE G
    Magy Belorv Arch (1955); 1958; 11(2-3):43-9. PubMed ID: 13599643
    [No Abstract]   [Full Text] [Related]  

  • 25. Biological characteristics of acute disseminated lupus erythematosus; modifications of the electrophoretic proteinogram and lupus cells.
    MAHAUX J; DENOLIN-REUBENS R; MASCART P
    Rev Hematol; 1953; 8(1):77-87. PubMed ID: 13101092
    [No Abstract]   [Full Text] [Related]  

  • 26. Storage histiocytes and hemophagocytosis: a common finding in the bone marrow of patients with active systemic lupus erythematosus.
    Morales-Polanco M; Jimenez-Balderas FJ; Yañez P
    Arch Med Res; 1996; 27(1):57-62. PubMed ID: 8867368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The L.E. cells of disseminated lupus erythematosus; research technic].
    DREYFUS B; FRANCOIS P
    Rev Fr Etud Clin Biol; 1956 May; 1(5):586-92. PubMed ID: 13351029
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bone marrow in lupus erythematosus].
    LEJMAN K; KOWARZ-SOKOLOWSKA H
    Przegl Dermatol; 1961; 48(Suppl)():159-72. PubMed ID: 14463939
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mepacrin in disseminated lupus erythematosus; report on 3 cases, of which 2 developed toxic bone marrow damage].
    HARSLOF E
    Nord Med; 1956 Jun; 55(24):839-41. PubMed ID: 13348924
    [No Abstract]   [Full Text] [Related]  

  • 30. [Spontaneous and induced production of Hargrave cells; value of L. E. phenomenon in diagnosis of acute disseminated lupus erythematosus].
    PIAGGIO BLANCO RA; PASEYRO P
    Arch Urug Med Cir Espec; 1952 Apr; 40(4):269-80. PubMed ID: 12977592
    [No Abstract]   [Full Text] [Related]  

  • 31. Lupus erythematosus cells in bone marrow: the only clue to a previously unsuspected diagnosis of systemic lupus erythematosus.
    Pujani M; Kushwaha S; Sethi N; Beniwal A; Shukla S
    Acta Cytol; 2013; 57(6):652-4. PubMed ID: 24107411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The L.E. cell and phenomenon in lupus erythematosus.
    BEERMAN H
    Am J Med Sci; 1951 Oct; 222(4):473-81. PubMed ID: 14885188
    [No Abstract]   [Full Text] [Related]  

  • 33. [Some data on bone marrow proliferation in patients with lupus erythematosus].
    GUMAROV VZ
    Vestn Dermatol Venerol; 1962 Nov; 36():31-3. PubMed ID: 13951258
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of inflammatory markers associated with systemic lupus erythematosus patients undergoing treatment.
    Timóteo RP; Micheli DC; Teodoro RB; Freire M; Bertoncello D; Murta EF; Tavares-Murta BM
    Rev Bras Reumatol Engl Ed; 2016; 56(6):497-503. PubMed ID: 27914596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Theoretical bases and experimental production in vitro of so-called lupus erythematosus phenomenon, L. E. phenomenon, in blood of normal subjects].
    CAPPELLI E
    Accad Medica; 1953 May; 68(5):131-2. PubMed ID: 13103988
    [No Abstract]   [Full Text] [Related]  

  • 36. The antigenic constituents of the neutrophilic leukocyte with special reference to the L. E. phenomenon.
    MIESCHER P
    Vox Sang; 1957 Jul; 2(3):145-58. PubMed ID: 13468363
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bone marrow hematopoiesis and peripheral blood in patients with lupus erythematosus].
    Glavinskaia TA; Klevtsova GI
    Vestn Dermatol Venerol; 1966 May; 40(5):17-23. PubMed ID: 5989826
    [No Abstract]   [Full Text] [Related]  

  • 38. [ACUTE DISSEMINATED LUPUS ERYTHEMATOSUS IN A FAMILY].
    VOLYNSKAIA Ia; IASHANOVA ND
    Arkh Patol; 1964; 26():71-4. PubMed ID: 14182515
    [No Abstract]   [Full Text] [Related]  

  • 39. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia.
    Bailey FA; Lilly M; Bertoli LF; Ball GV
    Arthritis Rheum; 1989 Jul; 32(7):901-5. PubMed ID: 2751721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus.
    Marqués JA; Rhim H; Distenfeld A
    P R Health Sci J; 1995 Dec; 14(4):293-6. PubMed ID: 8637971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.